Radiation Therapeutics and Oncology

61  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Yoshida M, Yoshimura RI, Notake R, Shinjo H, Miyaura K, Kuwayama T, Kawanaka T, Shien T, Yoshio K, Shiga T, Kaneyasu Y, Nakagawa T, Kubota K, Nakamura S, Itami J, Working group of APBI with SAVIs in Japan (WASAVIs): Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study. Breast cancer (Tokyo, Japan). 2024.01; 31 (1): 75-83. ( PubMed , DOI )

  2. Akane Masumoto, Kota Yokoyama, Meika Namba, Kazuma Sasamura, Ryo-Ichi Yoshimura: A Case of Radiation-Induced Brachial Plexopathy Below the Tolerance Dose. Cureus. 2024.01; 16 (1): e52283. ( PubMed , DOI )

  1. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y: Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; ( PubMed , DOI )

  2. Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa: The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer International Journal of Urology. 2023.07; 30 (7): 616-617. ( ichushi )

  3. Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T, Akiyama K, Onuma Y, Adachi T, Harada H, Nojima H, Miura M, Yoshimura R, Kabasawa Y: Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer. Heliyon. 2023.06; 9 (6): e15869. ( PubMed , DOI )

  4. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y: Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology. 2023.04; ( PubMed , DOI )

  5. Saito AI, Hirai T, Inoue T, Hojo N, Kawai S, Kato Y, Ito K, Kato M, Ozawa Y, Shinjo H, Toda K, Yoshimura RI: Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study. Anticancer research. 2023.02; 43 (2): 865-873. ( PubMed , DOI )

  6. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy International Journal of Urology. 2023.02; 30 (2): 204-210. ( ichushi )

  1. Hitomi Nojima, Atsushi Kaida, Takeshi Kuroshima, Ryo-Ichi Yoshimura, Masahiko Miura: Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer. Cureus. 2022.11; 14 (11): e31904. ( PubMed , DOI )

  2. Towithelertkul Cheewin, Sumita Yuka I., Murakami Toshihiro, Notake Ryoichi, Akiyama Masako, Yoshimura Ryoichi, Wakabayashi Noriyuki: Radiation attenuation properties of materials used to fabricate radiotherapy prostheses in vitro study(タイトル和訳中) Journal of Oral Science. 2022.10; 64 (4): 274-278. ( ichushi )

  3. Towithelertkul C, Sumita YI, Murakami T, Notake R, Akiyama M, Yoshimura R, Wakabayashi N: Radiation attenuation properties of materials used to fabricate radiotherapy prostheses in vitro study. J Oral Sci. 2022.09; online. ( PubMed , DOI )

  4. Noji R, Tohyama K, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Michi Y, Tasaki A, Ohno K, Ariizumi Y, Onishi I, Suenaga M, Mori T, Okamoto R, Yoshimura R, Miura M, Asakage T, Miyake S, Ikeda S, Harada H, Kano Y: Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers. 2022.07; 14 (14): ( PubMed , DOI )

  5. Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S: Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial. J Hepatobiliary Pancreat Sci. 2022.04; 29 (4): 487-499. ( PubMed , DOI )

  6. Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AY, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J: Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2022.04; 52 (8): 851-860. ( DOI )

  7. Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S: Safety and response after peptide receptor radionuclide therapy with 177Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial Journal of Hepato-Biliary-Pancreatic Sciences. 2022.04; 29 (4): 487-499. ( ichushi )

  8. Aya Usami, Kota Yokoyama, Junichi Tsuchiya, Yoshihiro Umezawa, Kazuma Toda, Ukihide Tateishi, Ryoichi Yoshimura: F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose. Diagnostics (Basel). 2022.02; 12 (2): ( PubMed , DOI )

  9. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii: Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers (Basel). 2022.01; 14 (3): 567. ( PubMed , DOI )

  1. Yoshimura Ryo-ichi, Toda Kazuma, Watanabe Hiroshi, Kaida Atsushi, Harada Hiroyuki, Asakage Takahiro, Miura Masahiko: Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer ANTICANCER RESEARCH. 2021.12; 41 (12): 6259-6266. ( PubMed , DOI )

  2. Noji R, Kano Y*(*corresponding author), Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H: MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral oncology. 2021.12; 124 105666. ( PubMed , DOI )

  3. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y: Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2021.12; ( PubMed , DOI )

  4. Kuroshima T, Onozato Y, Oikawa Y, Ohsako T, Kugimoto T, Hirai H, Tomioka H, Michi Y, Miura M, Yoshimura R, Harada H: Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study. Scientific reports. 2021.10; 11 (1): 20535. ( PubMed , DOI )

  5. Sasamura K, Soyano T, Kozuka T, Yuasa T, Yamamoto S, Yonese J, Oguchi M, Yoshimura R, Yoshioka Y: Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study. Japanese journal of clinical oncology. 2021.10; ( PubMed , DOI )

  6. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed , DOI )

  7. Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy IJU Case Reports. 2021.07; 4 (4): 228-230. ( ichushi )

  8. Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Tateishi Ukihide, Fujii Yasuhisa: Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer EUROPEAN RADIOLOGY. 2021.06; ( PubMed , DOI )

  9. Kabasawa Yuji, Ito Kanade, Tokura Shiori, Takazawa Itsuki, Kimura Rio, Nakanishi Tohko, Akiyama Kikue, Onuma Yuki, Adachi Toshiko, Komiya Ruri, Harada Hiroyuki, Nojima Hitomi, Miura Masahiko, Yoshimura Ryoichi: Clinical Investigation of Episil Oral Solution for Oral Mucositis during Radiochemical Treatment for Head and Neck Cancer 日本口腔ケア学会雑誌. 2021.04; 15 (3): 264. ( ichushi )

  10. Furusawa A, Takekuma M, Mori K, Usami T, Kondo E, Nishio S, Nishino K, Miyamoto Y, Yoshimura R, Watanabe M, Mikami M, Enomoto T: A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2021.03; ( PubMed , DOI )

  11. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International Journal of Urology. 2021.02; 28 (2): 241-242. ( ichushi )

  12. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed , DOI )

  13. Saito Kazutaka, Matsuoka Yoh, Toda Kazuma, Yoshida Soichiro, Yokoyama Minato, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer BRACHYTHERAPY. 2021; 20 (4): 842-848. ( PubMed , DOI )

  1. Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Takuya Nagano, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Akihiko Hoshi, Masayuki Kurosaki, Namiki Izumi: Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis. Hepatol Res. 2020.12; 50 (12): 1375-1385. ( PubMed , DOI )

  2. Kaneko Shun, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Takeguchi Takaya, Takeguchi Yuko, Nagano Takuya, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Hoshi Akihiko, Kurosaki Masayuki, Izumi Namiki: 肝機能と門脈腫瘍血栓症に基づく進行肝細胞癌に対する戦略(Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis) Hepatology Research. 2020.12; 50 (12): 1375-1385. ( ichushi )

  3. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International journal of urology : official journal of the Japanese Urological Association. 2020.11; ( PubMed , DOI )

  4. Towithelertkul C, Chugh A, Hattori M, Yoshimura R, Sumita YI: A custom-made brachytherapy applicator for recurrent endometrial and vaginal cancer: A dental technique for prosthesis fabrication. The Journal of prosthetic dentistry. 2020.11; ( PubMed , DOI )

  5. Clinical Results of Radiotherapy That Targeted for Tumor Thrombi from Hepatocellular Carcinoma: A Multicenter Retrospective Study 2020.10; ( DOI )

  6. Sasamura K, Suzuki R, Kozuka T, Yoshimura R, Yoshioka Y, Oguchi M: Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study. Journal of radiation research. 2020.08; ( PubMed , DOI )

  7. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y: Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 634-635. ( PubMed , DOI )

  8. Hirota Hiroshi, Ito Kei, Kageyama Shun-Ichiro, Tamamoto Fumihiko, Karasawa Katsuyuki, Yoshimura Ryouichi: Safety of radiotherapy for hemodialysis patients with cancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2020.05; 25 (5): 978-983. ( DOI )

  9. Hirai H, Ohsako T, Kugimoto T, Tomioka H, Michi Y, Kayamori K, Yoda T, Miura M, Yoshimura R, Harada H: Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma. Oral oncology. 2020.04; 107 104708. ( PubMed , DOI )

  10. Iijima Kotaro, Okamoto Hiroyuki, Takahashi Kana, Aikawa Ako, Wakita Akihisa, Nakamura Satoshi, Nishioka Shie, Harada Ken, Notake Ryoichi, Sugawara Akimoto, Yoshimura Ryoichi, Kunieda Etsuo, Itami Jun: Inter-fractional variations in the dosimetric parameters of accelerated partial breast irradiation using a strut-adjusted volume implant JOURNAL OF RADIATION RESEARCH. 2020.01; 61 (1): 123-133. ( PubMed , DOI )

  11. Iijima Kotaro, Okamoto Hiroyuki, Takahashi Kana, Aikawa Ako, Wakita Akihisa, Nakamura Satoshi, Nishioka Shie, Harada Ken, Notake Ryoichi, Sugawara Akimoto, Yoshimura Ryoichi, Kunieda Etsuo, Itami Jun: strut-adjusted volume implantを用いた加速乳房部分照射の線量パラメータにおけるinter-fractional variation(Inter-fractional variations in the dosimetric parameters of accelerated partial breast irradiation using a strut-adjusted volume implant) Journal of Radiation Research. 2020.01; 61 (1): 123-133. ( ichushi )

  12. Kunogi H, Hsu IC, Yamaguchi N, Kusunoki S, Nakagawa K, Sugimori Y, Fujino K, Terao Y, Ogishima D, Yoshimura R, Sasai K: CT-Guided Pelvic Lymph Nodal Brachytherapy. Frontiers in oncology. 2020; 10 532555. ( PubMed , DOI )

  1. Toda K., Sasamura K., Tateishi U., Yoshimura R. I.: Time Dependency of Textural Features Obtained by Dual-Time-Point TOF-PET/CT in Head and Neck Squamous Cell Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2019.09; 105 (1): S203-S204.

  2. Sasamura K, Matsubara D, Kojima M, Yuasa-Nakagawa K, Toda K, Miura K, Yoshimura R: Intensity Modulated Radiation Therapy for Syringomatous Carcinoma of the Face: A Case Report. Advances in radiation oncology. 2019.07; 4 (3): 473-477. ( PubMed , DOI )

  3. Yoshida S, Takahara T, Arita Y, Ishii C, Uchida Y, Nakagawa K, Toda K, Sakamoto T, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y: Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. International journal of radiation oncology, biology, physics. 2019.06; ( PubMed , DOI )

  4. Nagano Takuya, Yoshimura Ryo-ichi, Kojima Mio, Nakagawa Keiko, Toda Kazuma: Outcomes of radiotherapy in advanced external auditory canal cancer JOURNAL OF RADIATION RESEARCH. 2019.05; 60 (3): 380-386. ( DOI )

  5. Nagano Takuya, Yoshimura Ryo-ichi, Kojima Mio, Nakagawa Keiko, Toda Kazuma: 進行性外耳道癌における放射線療法の治療転帰(Outcomes of radiotherapy in advanced external auditory canal cancer) Journal of Radiation Research. 2019.05; 60 (3): 380-386. ( ichushi )

  6. Sato Kiyoshi, Shimamoto Hiroaki, Mochizuki Yumi, Hirai Hideaki, Tomioka Hirofumi, Shimizu Risa, Marukawa Eriko, Fukayama Haruhisa, Yoshimura Ryoichi, Ishida Hiroo, Harada Hiroyuki: Treatment of oral cancers during pregnancy: a case-based discussion JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY. 2019.02; 48 (1): 9. ( PubMed , DOI )

  7. Kuwabara Hirofumi, Toriihara Akira, Yuasa-Nakagawa Keiko, Toda Kazuma, Tateishi Ukihide, Yoshimura Ryoichi: Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2019.01; 41 (1): 103-109. ( PubMed , DOI )

  1. Yoshida Soichiro, Takahara Taro, Ishii Chikako, Nakagawa Keiko, Toda Kazuma, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 358.

  2. Yamaga Emi, Toriihara Akira, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Michi Yasuyuki, Harada Hiroyuki, Tateishi Ukihide: Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma(cT1-2NOMO) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( ichushi )

  3. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed , DOI )

  1. Toda K., Toriihara A., Nakagawa K., Kojima M., Nagano T., Tateishi U., Yoshimura R. I.: Time Dependency of Volume-Based Metabolic Parameters Obtained by Dual-Time-Point TOF-PET/CT for Head and Neck Squamous Cell Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017.10; 99 (2): E377-E378.

  2. Atsushi Kaida, Hiroshi Watanabe, Kazuma Toda, Keiko Yuasa-Nakagawa, Ryoichi Yoshimura, Masahiko Miura: Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using Ir-192 sources. Oral Radiol. 2017.09; 33 (3): 187-192. ( DOI )

  3. Sato M, Saitoh Y, Takayama T, Omata T, Watanabe H, Yoshimura R, Miura M.: Remote radioactive seed-loading device for permanent brachytherapy of oral cancer with Au-198 grains. Robomech Journal. 2017.09; 4 23.

  4. Kaida Atsushi, Watanabe Hiroshi, Toda Kazuma, Yuasa-Nakagawa Keiko, Yoshimura Ryoichi, Miura Masahiko: 舌可動部の癌に対する192Ir線源を用いた低線量率小線源治療における、初期及び晩期合併症に対する線量率の効果(Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using 192Ir sources) Oral Radiology. 2017.09; 33 (3): 187-192. ( ichushi )

  5. Toriihara Akira, Yamaga Emi, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Tateishi Ukihide: Prognostic prediction of early oral squamous cell carcinoma using FDG-PET/CT. JOURNAL OF NUCLEAR MEDICINE. 2017.05; 58

  6. Ozaki Y, Watanabe H, Kaida A, Miura M, Nakagawa K, Toda K, Yoshimura R, Sumi Y, Kurabayashi T: Estimation of whole-body radiation exposure from brachytherapy for oral cancer using Monte Carlo simulation. Journal of Radiation Research. 2017.02; 58 (4): 523-528. ( PubMed , DOI )

  1. Murakami N, Kato S, Nakano T, Yamanaka T, Sakurai H, Yoshimura R, Hiratsuka J, Kuroda Y, Yoshioka K, Itami J: A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. Bio Med Central Cancer. 2016.08; 16 (640): ( DOI )

  2. Taito Asahina, Atsushi Kaida, Tatsuaki Goto, Ryo-Ichi Yoshimura, Keisuke Sasai, Masahiko Miura: Temporo-spatial cell-cycle kinetics in HeLa cells irradiated by Ir-192 high dose-rate remote afterloading system (HDR-RALS). Radiat Oncol. 2016.07; 11 99. ( PubMed , DOI )

  1. Murakami N, Yoshimura R, et al: Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies Radiation Oncology. 2014.01; (9):

To the head of this page.▲